4 Recruiting Neurofibromatosis 1 Phase 2 Clinical Trials

Active phase 2 studies for neurofibromatosis 1 enrolling across the USA. Verify eligibility and contact site coordinators.

All Neurofibromatosis 1 studies

Phase 2 Studies for Neurofibromatosis 1

🔵 Active, Not Recruiting Phase1 / Phase2

AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors

📍 Children's National Medical Center — Washington D.C., District of Columbia

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2

Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1

📍 Children's Hospital Los Angeles — Los Angeles, California

View Study & Checklist ➔

🟢 Recruiting Phase2

Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1

📍 Childrens of Alabama — Birmingham, Alabama

View Study & Checklist ➔

🟢 Recruiting Phase1 / Phase2

Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas

📍 National Institutes of Health Clinical Center — Bethesda, Maryland

View Study & Checklist ➔